Literature DB >> 31205333

Impact of Implementing Smart Infusion Pumps in an Intensive Care Unit in Mexico: A Pre-Post Cost Analysis Based on Intravenous Solutions Consumption.

Erika Palacios Rosas1, Isaac F Soria-Cedillo2, Fabiola Puértolas-Balint1, Rebecca Ibarra-Pérez1, Sergio E Zamora-Gómez3, Elizabeth Lozano-Cruz3, Marcos A Amezcua-Gutiérrez3, Lucila I Castro-Pastrana1.   

Abstract

Background: The use of smart pump technology has shown to be profitable in the intensive care unit (ICU) because it avoids costs from prevented medication errors and allows for savings on disposables and medications by establishing standardized concentrations and dosing units. Objective: The objective of the study is to evaluate the economic impact of the implementation of smart infusion pumps in the consumption of intravenous (IV) solutions in an ICU.
Methods: A retrospective observational study was conducted with a pre-post design. The study occurred in the adult ICU of the Hospital Juárez de México. The pattern of consumption of IV solutions (sodium chloride 9%, Hartmann's solution, dextrose 5% and 10%, sodium chloride 0.9% with dextrose 5%) was analyzed preimplementation and postimplementation of 50 Plum A+™ pumps with Hospira MedNet™ security software. Using the TreeAge Pro 2016 software, deterministic and probabilistic analyses were carried out (10 000 Monte Carlo simulations) to confirm the robustness of the annual consumption comparison and the associated expenses before and after implementing smart technology.
Results: The implementation of the smart pumps reduced the annual consumption of IV solutions to 8994 units (18%) and 3649 liters (22.3%). In the first year, MXN$55 850.97 were saved. From an institutional perspective and with a probability of 0.63, the use of MedNet™ technology proved to be a lower cost alternative (17.1% saved) with respect to the conventional infusion systems.
Conclusion: The implementation of smart infusion pumps allows savings, specifically for the IV solutions used in ICU.

Entities:  

Keywords:  IV infusions; IV solutions.; cost analysis; intensive care; smart infusion pumps

Year:  2018        PMID: 31205333      PMCID: PMC6535929          DOI: 10.1177/0018578718786943

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  24 in total

1.  Insights from the sharp end of intravenous medication errors: implications for infusion pump technology.

Authors:  M Husch; C Sullivan; D Rooney; C Barnard; M Fotis; J Clarke; G Noskin
Journal:  Qual Saf Health Care       Date:  2005-04

2.  Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs.

Authors:  Neil A Halpern; Stephen M Pastores
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

3.  Impact of intelligent intravenous infusion pumps on directing care toward evidence-based standards: a retrospective data analysis.

Authors:  M Blane Schilling; Steven Sandoval
Journal:  Hosp Pract (1995)       Date:  2011-08

Review 4.  Nurses' risk without using smart pumps.

Authors:  Andrew D Harding; Mark W Connolly; Timothy O Wilkerson
Journal:  JONAS Healthc Law Ethics Regul       Date:  2011 Jan-Mar

5.  Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients.

Authors:  Gitte Y Larsen; Howard B Parker; Jared Cash; Mary O'Connell; MaryJo C Grant
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

6.  Technology utilization to prevent medication errors.

Authors:  Allison Forni; Hanh T Chu; John Fanikos
Journal:  Curr Drug Saf       Date:  2010-01

Review 7.  The impact of critical care pharmacists on enhancing patient outcomes.

Authors:  Sandra L Kane; Robert J Weber; Joseph F Dasta
Journal:  Intensive Care Med       Date:  2003-03-29       Impact factor: 17.440

8.  A controlled trial of smart infusion pumps to improve medication safety in critically ill patients.

Authors:  Jeffrey M Rothschild; Carol A Keohane; E Francis Cook; E John Orav; Elisabeth Burdick; Sarah Thompson; Judy Hayes; David W Bates
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

9.  Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy.

Authors:  Robert J Weber; Sandra L Kane; Vincent A Oriolo; Melissa Saul; Susan J Skledar; Joseph F Dasta
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

Review 10.  Clinical review: medication errors in critical care.

Authors:  Eric Moyen; Eric Camiré; Henry Thomas Stelfox
Journal:  Crit Care       Date:  2008-03-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.